MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide

著录项

• 来源
  《International Journal of Radiation Oncology, Biology, Physics》 |2017年第2suppla期|共2页
• 作者

  Bell E. H.; Won M.; Chang S. M.; Cairncross G.; Gilbert M.; Bahary J. P.; Dolinskas C.; Aldape K.; McElroy J.; Fleming J.; Ashby L.; Shih H. A.; Hunter G. K.; Yung W. A.; Howard S. P.; Belanger K.; Siker M. L.; Kavanagh B. D.; Chen Y.; Chakravarti A.;

  展开▼
• 作者单位

  Ohio State Univ Columbus OH 43210 USA;

  NRG Oncol Stat &

  Data Management Ctr Philadelphia PA USA;

  Univ Calif San Francisco San Francisco CA 94143 USA;

  Univ Calgary Calgary AB Canada;

  NCI Neurooncol Branch NIH Bethesda MD 20892 USA;

  Univ Montreal Montreal PQ Canada;

  Penn Hosp Philadelphia PA 19107 USA;

  Princess Margaret Hosp Toronto ON Canada;

  Ohio State Univ Ctr Biostat Columbus OH 43210 USA;

  Ohio State Univ Columbus OH 43210 USA;

  St Josephs Hosp Phoenix AZ USA;

  Massachusetts Gen Hosp Boston MA 02114 USA;

  Intermt Healthcare Murray UT USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Wisconsin Hosp &

  Clin Dept Human Oncol Madison WI 53792 USA;

  CHUM Hosp Notre Dame Montreal PQ Canada;

  Med Coll Wisconsin Milwaukee WI 53226 USA;

  Univ Colorado Denver Dept Radiat Oncol Aurora CO USA;

  Univ Rochester Wilmot Canc Inst Rochester NY USA;

  Ohio State Univ Columbus OH 43210 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 放射医学;
• 关键词